Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 19, 2016SHILAP Revista de lepidopterologíaOpen Access

The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test

View Full Paper
Ask AI
Bookmark
Share

Authors

SHS HametnerAFArnulf FerlitschMFMonika Ferlitsch

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hametner et al. (2016) studied this question.

synapsesocial.com/papers/69dd1e7e854f360ad6359b14https://doi.org/10.1371/journal.pone.0149230
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension2011 · 183 citations
  2. 2von Willebrand Factor Antigen: A Novel On-Treatment Predictor of Response to Antiviral Therapy in Chronic Hepatitis C Genotypes 1 and 42010 · 12 citations
  3. 3Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension2010 · 2,296 citations